PAION’s mission is to be a leading specialty pharmaceutical company in the fields of anesthesia and critical care by bringing novel products to market to benefit patients, doctors and other stakeholders in healthcare.
Teleconference & webcast
30 March 2022
PAION LAUNCHES ERAVACYCLINE FOR THE TREATMENT OF COMPLICATED INTRA-ABDOMINAL...
DGAP-News: PAION AG / Key word(s): Market Launch PAION LAUNCHES...
PAION REPORTS SOLID PROGRESS WITH COMMERCIAL ACTIVITIES IN EUROPE
DGAP-News: PAION AG / Key word(s): Miscellaneous PAION...
PAION AG: ANNUAL GENERAL MEETING APPROVES ALL AGENDA ITEMS AND ELECTS...
DGAP-News: PAION AG / Key word(s): AGM/EGM PAION AG:...
I consent to the display of external content. This enables personal data to be transmitted to third-party platforms. Read more about our